Steven Cohen’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.9M Buy
+108,615
New +$11.7M 0.02% 886
2026
Q2
– Sell
-197,844
Closed -$10.2M – 4390
2026
Q1
$10.1M Buy
+197,844
New +$9.23M 0.01% 1252
2019
Q1
– Sell
-50,000
Closed -$764K – 1149
2018
Q4
$764K Buy
+50,000
New +$822K ﹤0.01% 835

Other funds holding MRNA

Steven Cohen's MRNA Position: Q3 2026 in Review

Steven Cohen opened a new position in Moderna (MRNA) in Q3 2026: 108,615 shares worth $20.9M. The stake represents 0.02% of the portfolio and ranks #886 among its holdings. This is a return to the name: Steven Cohen previously reported a position in MRNA as recently as Q1 2026.

Steven Cohen first reported a position in MRNA in Q4 2018 and has held it in 3 quarters since. 1,033 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Steven Cohen held 108,615 shares of Moderna worth $20.9M as of Q3 2026.
  • Moderna was a new Steven Cohen position in Q3 2026.
  • Moderna made up 0.02% of Steven Cohen's portfolio in Q3 2026, its #886 holding.
  • Steven Cohen first reported a position in Moderna in Q4 2018 and has held it in 3 quarters since.
  • 1,033 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.